Nebulized morphine for paroxysmal cough and dyspnea in a nursing home resident with metastatic cancer

Abstract

Get full access to this article

View all access options for this article.

References

Doyle D , Hanks G , MacDonald N : Introduction. In Doyle D, Hanks GWC, MacDonald N: Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press. 1993: 3-8.

Stephany T : Nebulized morphine: Another point of view. Am J Hosp Palliat Care. Sept-Oct 1995;12(5): 7.

Davis CL , Lam W , Butcher M , et al : Low systemic bioavailability of nebulised morphine: Potential therapeutic role for the relief of dyspnea. Br J Cancer. 1992;65 (suppl. 16): 12.

Farncombe M , Chater S : Case studies outlining use of nebulized morphine for patients with end stage chronic lung and cardiac disease. J Pain Symptom Manage. 1993. 8(4): 221-225.

Ahmedzai S : Palliation of respiratory symptoms. In Doyle, D, Hanks, GWC, and MacDonald, N. Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press. 1993: 362-364.

Davis CL , Hardy JR : Palliative care. BMJ. May 1994. 308:1359-1362.

Dudgeon D : Dyspnea: Ethical Concerns. J Pall Care. 1993. 10(3): 48-51.

Farncombe M , Chater S , Gillin A : The use of nebulized morphine for breathlessness: A chart review. Pall Med. 1994. 8:306-312.

Howe JL : Nebulized morphine for hospice patients. Am J Hosp Palliat Care. Sept-Oct 1995. 12(5): 6.

10.

Nelson K , Walsh D : Management of dyspnea in advanced cancer. Cancer Bull. 1991. 43(5): 423-426.

11.

Regnard C , Ahmedzai S : Dyspnea in advanced nonmalignant disease—A flow diagram. Pall Med. 1991. 5:56-60.

12.

Young IH , Daviskas E , Keena VA . Effect of low dose nebulized morphine on exercise endurance in patients with chronic lung disease. Thorax. 1989. 44:387-390.